The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions

Claudia Piccoli, Annamaria D'Aprile, Maria Ripoli, Rosella Scrima, Domenico Boffoli, Antonio Tabilio, Nazzareno Capitanio

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The hypoxia-inducible factor (HIF) transcriptional system enables cell adaptation to limited O2 availability, transducing this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, and altered energy metabolism, as well as cell survival decisions. However, other factors beyond hypoxia are known to activate this pleiotropic transcription factor. The aim of this study was to characterize HIF in human hematopoietic stem cells (HSCs) and evidence is provided that granulocyte colony stimulating factor-mobilized CD34+- and CD133+-HSCs express a stabilized cytoplasmic form of HIF-1α under normoxic conditions. It is shown that HIF-1α stabilization correlates with down-regulation of the tumour suppressor von Hippel-Lindau protein (pVHL) and is positively controlled by NADPH-oxidase-dependent production of reactive oxygen species, indicating a specific O2-independent post-transcriptional control of HIF in mobilized HSCs. This novel finding is discussed in the context of the proposed role of HIF as a mediator of progenitor cell recruitment to injured ischemic tissues and/or in the control of the maintenance of the undifferentiated state.

Original languageEnglish
Pages (from-to)3111-3119
Number of pages9
JournalFEBS Letters
Volume581
Issue number16
DOIs
Publication statusPublished - Jun 26 2007

Fingerprint

Hematopoietic Stem Cells
Stem cells
Hypoxia-Inducible Factor 1
Von Hippel-Lindau Tumor Suppressor Protein
NADPH Oxidase
Granulocyte Colony-Stimulating Factor
Reactive Oxygen Species
Transcription Factors
Stabilization
Cells
Availability
Tissue
Erythropoiesis
Energy Metabolism
Cell Survival
Stem Cells
Down-Regulation
Maintenance
Hypoxia

Keywords

  • Hematopoietic stem cells
  • HIF
  • NADPH oxidase
  • pVHL
  • Redox signalling

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Piccoli, C., D'Aprile, A., Ripoli, M., Scrima, R., Boffoli, D., Tabilio, A., & Capitanio, N. (2007). The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions. FEBS Letters, 581(16), 3111-3119. https://doi.org/10.1016/j.febslet.2007.05.077

The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions. / Piccoli, Claudia; D'Aprile, Annamaria; Ripoli, Maria; Scrima, Rosella; Boffoli, Domenico; Tabilio, Antonio; Capitanio, Nazzareno.

In: FEBS Letters, Vol. 581, No. 16, 26.06.2007, p. 3111-3119.

Research output: Contribution to journalArticle

Piccoli, C, D'Aprile, A, Ripoli, M, Scrima, R, Boffoli, D, Tabilio, A & Capitanio, N 2007, 'The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions', FEBS Letters, vol. 581, no. 16, pp. 3111-3119. https://doi.org/10.1016/j.febslet.2007.05.077
Piccoli, Claudia ; D'Aprile, Annamaria ; Ripoli, Maria ; Scrima, Rosella ; Boffoli, Domenico ; Tabilio, Antonio ; Capitanio, Nazzareno. / The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions. In: FEBS Letters. 2007 ; Vol. 581, No. 16. pp. 3111-3119.
@article{b40ff8741e924819a7eb5821e92ba456,
title = "The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions",
abstract = "The hypoxia-inducible factor (HIF) transcriptional system enables cell adaptation to limited O2 availability, transducing this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, and altered energy metabolism, as well as cell survival decisions. However, other factors beyond hypoxia are known to activate this pleiotropic transcription factor. The aim of this study was to characterize HIF in human hematopoietic stem cells (HSCs) and evidence is provided that granulocyte colony stimulating factor-mobilized CD34+- and CD133+-HSCs express a stabilized cytoplasmic form of HIF-1α under normoxic conditions. It is shown that HIF-1α stabilization correlates with down-regulation of the tumour suppressor von Hippel-Lindau protein (pVHL) and is positively controlled by NADPH-oxidase-dependent production of reactive oxygen species, indicating a specific O2-independent post-transcriptional control of HIF in mobilized HSCs. This novel finding is discussed in the context of the proposed role of HIF as a mediator of progenitor cell recruitment to injured ischemic tissues and/or in the control of the maintenance of the undifferentiated state.",
keywords = "Hematopoietic stem cells, HIF, NADPH oxidase, pVHL, Redox signalling",
author = "Claudia Piccoli and Annamaria D'Aprile and Maria Ripoli and Rosella Scrima and Domenico Boffoli and Antonio Tabilio and Nazzareno Capitanio",
year = "2007",
month = "6",
day = "26",
doi = "10.1016/j.febslet.2007.05.077",
language = "English",
volume = "581",
pages = "3111--3119",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "16",

}

TY - JOUR

T1 - The hypoxia-inducible factor is stabilized in circulating hematopoietic stem cells under normoxic conditions

AU - Piccoli, Claudia

AU - D'Aprile, Annamaria

AU - Ripoli, Maria

AU - Scrima, Rosella

AU - Boffoli, Domenico

AU - Tabilio, Antonio

AU - Capitanio, Nazzareno

PY - 2007/6/26

Y1 - 2007/6/26

N2 - The hypoxia-inducible factor (HIF) transcriptional system enables cell adaptation to limited O2 availability, transducing this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, and altered energy metabolism, as well as cell survival decisions. However, other factors beyond hypoxia are known to activate this pleiotropic transcription factor. The aim of this study was to characterize HIF in human hematopoietic stem cells (HSCs) and evidence is provided that granulocyte colony stimulating factor-mobilized CD34+- and CD133+-HSCs express a stabilized cytoplasmic form of HIF-1α under normoxic conditions. It is shown that HIF-1α stabilization correlates with down-regulation of the tumour suppressor von Hippel-Lindau protein (pVHL) and is positively controlled by NADPH-oxidase-dependent production of reactive oxygen species, indicating a specific O2-independent post-transcriptional control of HIF in mobilized HSCs. This novel finding is discussed in the context of the proposed role of HIF as a mediator of progenitor cell recruitment to injured ischemic tissues and/or in the control of the maintenance of the undifferentiated state.

AB - The hypoxia-inducible factor (HIF) transcriptional system enables cell adaptation to limited O2 availability, transducing this signal into patho-physiological responses such as angiogenesis, erythropoiesis, vasomotor control, and altered energy metabolism, as well as cell survival decisions. However, other factors beyond hypoxia are known to activate this pleiotropic transcription factor. The aim of this study was to characterize HIF in human hematopoietic stem cells (HSCs) and evidence is provided that granulocyte colony stimulating factor-mobilized CD34+- and CD133+-HSCs express a stabilized cytoplasmic form of HIF-1α under normoxic conditions. It is shown that HIF-1α stabilization correlates with down-regulation of the tumour suppressor von Hippel-Lindau protein (pVHL) and is positively controlled by NADPH-oxidase-dependent production of reactive oxygen species, indicating a specific O2-independent post-transcriptional control of HIF in mobilized HSCs. This novel finding is discussed in the context of the proposed role of HIF as a mediator of progenitor cell recruitment to injured ischemic tissues and/or in the control of the maintenance of the undifferentiated state.

KW - Hematopoietic stem cells

KW - HIF

KW - NADPH oxidase

KW - pVHL

KW - Redox signalling

UR - http://www.scopus.com/inward/record.url?scp=34250163925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250163925&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2007.05.077

DO - 10.1016/j.febslet.2007.05.077

M3 - Article

VL - 581

SP - 3111

EP - 3119

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 16

ER -